Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC).

Details

Language :

English

ISSN :

15560864

Volume :

3

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

115810646

Full Text :

https://doi.org/10.1097/JTO.0b013e318189f50e